Literature DB >> 6944528

Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.

M H Tan, T Shimano, T M Chu.   

Abstract

Tissue localization of a human pancreas cancer-associated antigen (PCAA) and carcinoembryonic antigen (CEA) was studied in a homologous pancreatic tumoral xenograft, a human pancreatic cancer line established from ascites (AsPC-1), with the use of the indirect immunofluorescence technique with specific anti-PCAA and anti-CEA antisera. Histologically, AsPC-1 xenograft was composed of mucinous adenocarcinoma of variable size and degree of glandular differentiation. PCAA was selectively associated with the columnar cytoplasm, was involved primarily in the epithelial proliferation, and originated at the basal aspect of the glands. In contrast, CEA appeared diffuse and was found predominantly in the cuboidal cells, with higher intensity at the luminal border and in mucin. Furthermore, growth comparison of the AsPC-1 adenocarcinoma revealed that, except in the juvenile gland that was morphologically consistent with grade 1 (G1) carcinoma in situ, the number of PCAA-positively stained cells decreased from G1 to grade 4 epithelial differentiation. In well-differentiated adenocarcinoma and degenerating adenocarcinoma, cells positive for PCAA were released into the lumen of the glands, whereas in poorly differentiated adenocarcinoma these cells were often scattered singly and/or in focal clusters and disappeared in very poorly differentiated adenocarcinoma. This study showed that the PCAA was different from CEA in its immunologic reactivity and distribution in its homologous tumoral tissues, in which PCAA was predominantly associated with the proliferative phase of the malignant epithelium. These results also indicated the potential applicability of this antigenic expression in the etiology, disease grading, and staging of human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6944528

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

1.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model.

Authors:  Xiaoling Ni; Jingxuan Yang; Min Li
Journal:  Cancer Lett       Date:  2012-05-19       Impact factor: 8.679

3.  Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.

Authors:  Paul T Winnard; Santosh K Bharti; Marie-France Penet; Radharani Marik; Yelena Mironchik; Flonne Wildes; Anirban Maitra; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

4.  Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.

Authors:  Hubert G Hotz; Parkash S Gill; Rizwan Masood; Birgit Hotz; Heinz J Buhr; Thomas Foitzik; O Joe Hines; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

5.  Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.

Authors:  Hubert G Hotz; O Joe Hines; Birgit Hotz; Thomas Foitzik; Heinz J Buhr; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2003-02       Impact factor: 3.452

6.  Quantitative Super-Resolution Imaging for the Analysis of GPCR Oligomerization.

Authors:  Megan D Joseph; Elena Tomas Bort; Richard P Grose; Peter J McCormick; Sabrina Simoncelli
Journal:  Biomolecules       Date:  2021-10-12

7.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

8.  Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites.

Authors:  W H Chen; J S Horoszewicz; S S Leong; T Shimano; R Penetrante; W H Sanders; R Berjian; H O Douglass; E W Martin; T M Chu
Journal:  In Vitro       Date:  1982-01

9.  The partial characterization and clinical evaluation of pancreas cancer-associated antigen from the ascites fluid of a patient with pancreatic cancer.

Authors:  M Saito; T Shimano; T Kobayashi; H Inaji; N Matsuura; S Masutani; T Mori
Journal:  Jpn J Surg       Date:  1991-07

10.  G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro.

Authors:  J H Lee; H J Federoff; L O Schoeniger
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.